# FDA Inspection 1223756 - David J. Seiden, M.D. - November 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/david-j-seiden-md/7c3d574c-acbb-447d-9ab2-59f5e34c9f3e
Source feed: FDA_Inspections

> FDA Inspection 1223756 for David J. Seiden, M.D. on November 17, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223756
- Company Name: David J. Seiden, M.D.
- Inspection Date: 2023-11-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 892915 - 2014-08-21](https://www.keypedia.com/records/fda_inspections/david-j-seiden-md/23514558-6a50-4b71-86bf-cfd46e817d23)
- [FDA Inspection 591261 - 2009-06-19](https://www.keypedia.com/records/fda_inspections/david-j-seiden-md/1b1bc6d1-3824-4140-bac6-40a3d0b6a998)

Company: https://www.keypedia.com/companies/david-j-seiden-md/c2dcd831-a6a2-40ec-aaef-3fe771cb4b1c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c